Ciliary neurotrophic factor implant - Microbot Medical

Drug Profile

Ciliary neurotrophic factor implant - Microbot Medical

Alternative Names: Ciliary neurotrophic factor implant -; CNTF implant -

Latest Information Update: 13 Dec 2016

Price : $50

At a glance

  • Originator StemCells; University of Lausanne
  • Developer StemCells
  • Class Eye disorder therapies; Obesity therapies
  • Mechanism of Action Ciliary neurotrophic factor replacements
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • On Fast track

    Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Discontinued Amyotrophic lateral sclerosis

Most Recent Events

  • 28 Nov 2016 StemCells has been acquired by Microbot Medical
  • 24 May 2000 Discontinued-I for Amyotrophic lateral sclerosis in USA (Intracranial)
  • 28 Jan 1998 New profile
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top